Delivery Order SPE2DB20D3303-SPE2DB24FA0ZC

Award Date 7/12/24
Potential Completion Date 8/2/24
Potential Value $4.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $19,198.52 firm fixed price delivery order is for the supply of the pharmaceutical product LONSURF 20 MG-8.19 MG TABLET 60S. This delivery order falls under a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA to provide a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,406.92, is for the delivery of the medication LONSURF 20 MG-8.19 MG TABLET 20S. The contract is a Firm Fixed Price Delivery Order with a completion date of February 6, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LONSURF 20 MG-8.19 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $10,173.33 and a completion date of February 28, 2025. The award was made on February 6, 2025, and there was no set-aside designation used. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,124.17, is a Firm Fixed Price Delivery Order for a pharmaceutical product called LONSURF 15 MG-6.14 MG TABLET 40S. The award has an ultimate completion date of February 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,124.17, is for the supply of the drug LONSURF 15 MG-6.14 MG TABLET 40S. The contract has an ultimate completion date of April 4, 2025 and a firm fixed price pricing type. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp also holds a $999,999,999 Indefinite...
This federal contract award, valued at $9,583.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LONSURF 15 MG-6.14 MG tablets, a medication used in the treatment of various medical conditions. The contract has an ultimate completion date of October 7, 2024 and is structured as a firm fixed-price delivery order. AmerisourceBergen holds a significant...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Lonsurf 15 mg-6.14 mg tablets in quantities of 20 per package. The contract has a ceiling value of $10,156.60 and is a firm fixed-price delivery order contract with a completion date of February 6, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of LONSURF 20 MG-8.19 MG tablets. The $8,531.96 firm-fixed-price contract has an ultimate completion date of October 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of LONSURF 15 MG-6.14 MG TABLET 20S, a prescription medication, with a ceiling value of $2,395.86 and a period of performance through September 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of...
This federal contract award, with an ID of SPE2DB22D3016|SPE2DB24FAQS5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The award is for the delivery of LONSURF 20 MG-8.19 MG tablets, with a ceiling value of $9,599.25 and a period of performance through April 12, 2024. This contract appears to be a firm fixed price delivery order issued under a larger...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA0ZC
    Delivery Order

This federal contract award is for the delivery of LONSURF 15 MG-6.14 MG TABLET 40S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,835.01 and is a Firm Fixed Price Delivery Order awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has no set-aside designation and has an ultimate completion date of August 2, 2024. Amerisourcebergen Drug Corp's Corporate Office Division holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.

Generated 10/11/24, 9:33 AM